A detailed history of Xtx Topco LTD transactions in Alector, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 28,590 shares of ALEC stock, worth $52,891. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,590
Previous 31,069 7.98%
Holding current value
$52,891
Previous $141,000 5.67%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.34 - $6.58 $10,758 - $16,311
-2,479 Reduced 7.98%
28,590 $133,000
Q2 2024

Aug 12, 2024

BUY
$4.19 - $6.23 $50,187 - $74,622
11,978 Added 62.74%
31,069 $141,000
Q1 2024

May 13, 2024

SELL
$5.69 - $8.08 $263,942 - $374,806
-46,387 Reduced 70.84%
19,091 $114,000
Q4 2023

Feb 13, 2024

BUY
$3.77 - $8.39 $106,736 - $237,537
28,312 Added 76.18%
65,478 $522,000
Q3 2023

Nov 13, 2023

BUY
$5.2 - $8.77 $132,282 - $223,100
25,439 Added 216.93%
37,166 $240,000
Q2 2023

Aug 14, 2023

BUY
$5.86 - $7.93 $68,720 - $92,995
11,727 New
11,727 $70,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $153M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.